Tourmaline Bio Inc. (TRML) — Financial Flexibility Index
Tourmaline Bio Inc. (TRML) has a Financial Flexibility Index of -2.01x as of June 2025. Free cash flow of $-20.26 Million (operating CF $-20.26 Million minus capex $7.00K) represents -2% of total liabilities ($10.10 Million). Also explore TRML net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tourmaline Bio Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Tourmaline Bio Inc. across 6 annual periods. Check Tourmaline Bio Inc. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tourmaline Bio Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Tourmaline Bio Inc.. For the full company profile including market capitalisation, see market value of Tourmaline Bio Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.63x | $-77.25 Million | $-77.26 Million | $8.95 Million | ▼ -61.8% |
| 2023 | -5.34x | $-28.02 Million | $-28.08 Million | $5.25 Million | ▼ -10965.4% |
| 2022 | -0.05x | $-1.39 Million | $-6.46 Million | $28.83 Million | ▲ +98.9% |
| 2021 | -4.36x | $-37.55 Million | $-39.99 Million | $8.61 Million | ▼ -16.1% |
| 2020 | -3.76x | $-17.93 Million | $-19.21 Million | $4.77 Million | ▲ +48.3% |
| 2019 | -7.26x | $-17.10 Million | $-17.66 Million | $2.35 Million | — |